ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN SUPPORTIVE CARE OF LOW-RISK MYELODYSPLASTIC SYNDROMES

被引：0
|
作者：
Cerchione, C. [1 ]
Alfinito, F. [2 ]
Soriente, I. [3 ]
D'Arco, A. M. [3 ]
Danise, P. [3 ]
Cerciello, G. [3 ]
Musuraca, G. [1 ]
Lucchesi, A. [1 ]
Di Battista, V. [1 ]
Cangini, D. [1 ]
Giannini, M. B. [1 ]
Ronconi, S. [1 ]
Ceccolini, M. [1 ]
Pane, F. [2 ]
Martinelli, G. [1 ]
机构：
[1] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Hematol Unit, Meldola, Italy
[2] AOU Federico II, Hematol, Naples, Italy
[3] Osped Pagani, Hematol, Pagani, Italy
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P001
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [1] SUPPORTIVE CARE IN LOW-RISK MYELODYSPLASTIC SYNDROMES: ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS)
    Cerchione, C.
    Alfinito, F.
    Soriente, I.
    D'Arco, A. M.
    Danise, P.
    Cerciello, G.
    Musuraca, G.
    Lucchesi, A.
    Di Battista, V.
    Cangini, D.
    Giannini, M. B.
    Ronconi, S.
    Ceccolini, M.
    Pane, F.
    Martinelli, G.
    HAEMATOLOGICA, 2022, 107 : 65 - 66
  • [2] ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN SUPPORTIVE CARE OF LOW-RISK MYELODYSPLASTIC SYNDROMES
    Cerchione, C.
    Martinelli, G.
    Soriente, I.
    D'Arco, A. M.
    Danise, P.
    Cerciello, G.
    Di Battista, V.
    Cangini, D.
    Giannini, M. B.
    Pane, F.
    Alfinito, F.
    HAEMATOLOGICA, 2019, 104 : 147 - 148
  • [3] Supportive Care in Low-Risk Myelodysplastic Syndromes: Role of Erythropoiesis Stimulating Agents (ESAs)
    Cerchione, Claudio
    Alfinito, Fiorella
    Giannini, Benedetta Maria
    Pane, Fabrizio
    Musuraca, Gerardo
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S318 - S318
  • [4] Role of Erythropoiesis-Stimulating Agents (ESAs) in Supportive Care of Low-Risk Myelodysplastic Syndromes
    Cerchione, Claudio
    Alfinito, Fiorella
    Soriente, Ilaria
    D'Arco, Alfonso Maria
    Danise, Paolo
    Cerciello, Giuseppe
    Pane, Fabrizio
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S324 - S325
  • [5] Erythropoiesis Stimulating Agents (ESAS) in Supportive Care of Low-Risk Myelodysplastic Syndromes: Recamds Registry FINAL Results
    Cerchione, Claudio
    Alfinito, Fiorella
    Vitagliano, Orsola
    Soriente, Ilaria
    Danise, Paolo
    Cerciello, Giuseppe
    Pane, Fabrizio
    Martinelli, Giovanni
    BLOOD, 2021, 138
  • [6] Management of anemia in low-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents
    Castelli, Roberto
    Schiavon, Riccardo
    Rossi, Valentina
    Deliliers, Giorgio Lambertenghi
    MEDICAL ONCOLOGY, 2018, 35 (05)
  • [7] Management of anemia in low-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents
    Roberto Castelli
    Riccardo Schiavon
    Valentina Rossi
    Giorgio Lambertenghi Deliliers
    Medical Oncology, 2018, 35
  • [8] MYELODYSPLASTIC SYNDROMES AND ERYTHROPOIESIS STIMULATING AGENTS (ESAS) : EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE
    Cerchione, C.
    Vitagliano, O.
    Cerciello, G.
    Pareto, A. E.
    Di Perna, M.
    Soriente, I.
    D'Arco, A. M.
    Danise, P.
    Alfinito, F.
    Pane, F.
    HAEMATOLOGICA, 2016, 101 : S115 - S115
  • [9] MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS (ESAS): A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Vitagliano, O.
    Pareto, A. E.
    Di Perna, M.
    Cerciello, G.
    Soriente, I.
    Alfinito, F.
    Pane, F.
    HAEMATOLOGICA, 2016, 101 : 840 - 840
  • [10] Supportive therapy for low-risk myelodysplastic syndromes
    Gay, Julie
    HEMATOLOGIE, 2008, 14 (03): : 178 - 184
12345